Abstract

The in-vivo study of the cell cycle in human tumors with the labeled mitosis curve is possible if the choice of patient conforms to certain criteria. In four of our cases good data were obtained, T8 varied between 7 and 19 hours and Tc between 1 day and 4 days. In two of the patients the shape of the curve suggests large fluctuations of the durations of the various phases of the cell cycle. For the third patient the peak of the labeled mitosis curve never exceeds 50%; this large spread of the duration of the phases of the cell cycle within the tumor cell population may be due to previous treatment of his tumor. There is a large discrepancy between the clinical doubling time and the potential doubling time computed on the basis of Tc and GF and assuming no cell loss. This discrepancy seems to indicate that the extent of cell loss is a major parameter of the growth rate of human tumors.

Keywords

Doubling timeMitosisCell cyclePopulationIn vivoCell growthCellMedicineGrowth curve (statistics)BiologyInternal medicineCell biologyMathematicsCancerStatisticsBiochemistryGenetics

Affiliated Institutions

Related Publications

Publication Info

Year
1968
Type
article
Volume
22
Issue
3
Pages
611-620
Citations
137
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

137
OpenAlex

Cite This

E. Frindel Malaise, M Tubiana (1968). Cell proliferation kinetics in five human solid tumors. Cancer , 22 (3) , 611-620. https://doi.org/10.1002/1097-0142(196809)22:3<611::aid-cncr2820220317>3.0.co;2-i

Identifiers

DOI
10.1002/1097-0142(196809)22:3<611::aid-cncr2820220317>3.0.co;2-i